InvestorsHub Logo
Followers 118
Posts 1968
Boards Moderated 0
Alias Born 11/22/2017

Re: None

Sunday, 01/20/2019 7:20:28 PM

Sunday, January 20, 2019 7:20:28 PM

Post# of 731900
Here is a quote from the latest PR from Northwest Biotherapeutics:

“Now that the data from our Phase 3 clinical trial of DCVax®-L have further matured and provided a further encouraging picture of patient survival, and we are ready to move forward with the months of work related to completion of the trial, we are very pleased to have a new war chest of funding for this work,” commented Linda Powers, CEO of NW Bio. “We are also looking forward to proceeding with further DCVax®-Direct trials.”
“We are especially pleased to obtain this funding on a non-dilutive basis, and to seamlessly continue our activities with the UK manufacturing facility under the favorable lease-back.”


https://nwbio.com/nw-bio-announces-non-dilutive-funding-of-approximately-47-3-million-through-uk-property-transaction/

This is what the Germans say:

„Wir freuen uns, das Jahr mit den jüngsten aktualisierten Zwischenergebnissen aus unserer Phase-3-Studie mit DCVax-L für Glioblastome stark abzuschließen. Diese britische Transaktion bietet uns einen beträchtlichen finanziellen Spielraum an nicht verwässernder Finanzierung“, erklärte Linda Powers, CEO von NW Bio.
„Wir glauben, dass wir mit diesen Erfolgen einen wichtigen Schritt gemacht haben, um dem seit Monaten angestrebten Abschluss der Phase-3-Studie deutlich näher zu kommen“, so Frau Powers weiter. „Wir freuen uns auch darauf, die Phase-2-Studien mit DCVax®-Direct fortzusetzen.“


http://preisagenturen-halle.shopping-me.de/?p=18707

Google Translate:

"We look forward to closing the year with the most recent updated interim results from our Phase 3 DCVax-L trial for glioblastoma. This UK deal gives us considerable financial leeway in non-dilutive financing, "said Linda Powers, CEO of NW Bio.

"We believe that with these achievements, we have made an important step towards coming much closer to the completion of the Phase 3 study, which has been going on for months," Ms. Powers continued. "We also look forward to continuing the Phase 2 studies with DCVax®-Direct."


http://preisagenturen-halle.shopping-me.de/?p=18707
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News